Suppr超能文献

HV-BBI——一种新型的两栖动物皮肤类鲍曼-伯克胰蛋白酶抑制剂。

HV-BBI--a novel amphibian skin Bowman-Birk-like trypsin inhibitor.

作者信息

Song Ganhong, Zhou Mei, Chen Wei, Chen Tianbao, Walker Brian, Shaw Chris

机构信息

Molecular Therapeutics Research, School of Pharmacy, Queen's University, McClay Research Centre, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland, UK.

出版信息

Biochem Biophys Res Commun. 2008 Jul 18;372(1):191-6. doi: 10.1016/j.bbrc.2008.05.035. Epub 2008 May 16.

Abstract

Here we describe the isolation of a novel C-terminally amidated octadecapeptide--SVIGCWTKSIPPRPCFVK-amide--that contains a disulphide loop between Cys(5) and Cys(15) that is consistent with a Bowman-Birk type protease inhibitor, from the skin secretion of the Chinese Bamboo odorous frog, Huia versabilis. Named HV-BBI, the peptide is encoded by a single precursor of 62 amino acid residues whose primary structure was deduced from cloned skin cDNA. The precursor exhibits the typical organization of that encoding an amphibian skin peptide with a highly-conserved signal peptide, an intervening acidic amino acid residue-rich domain and a single HV-BBI-encoding domain located towards the C-terminus. A synthetic replicate of HV-BBI, with the wild-type K (Lys-8) residue in the presumed P1 position, was found to be a potent inhibitor of trypsin with a K(i) just slightly less than 19 nM. Substitution at this site with R (Arg) resulted in a significant reduction in potency (K(i) 57 nM), whereas replacement of K with F (Phe) resulted in the complete abolition of trypsin inhibitory activity. Thus, HV-BBI is a potent inhibitor of trypsin and the lysyl (K) residue that occupies the P1 position appears to be optimal for potency of action against this protease.

摘要

在此,我们描述了一种新型C末端酰胺化十八肽——SVIGCWTKSIPPRPCFVK-酰胺的分离过程,该十八肽在半胱氨酸(Cys)(5)和半胱氨酸(Cys)(15)之间含有一个二硫键环,这与鲍曼-伯克(Bowman-Birk)型蛋白酶抑制剂一致,它是从中国竹臭蛙(Huia versabilis)的皮肤分泌物中分离得到的。该肽被命名为HV-BBI,由一个62个氨基酸残基的单一前体编码,其一级结构是从克隆的皮肤cDNA推导出来的。该前体呈现出编码两栖动物皮肤肽的典型结构,具有高度保守的信号肽、一个富含酸性氨基酸残基的中间结构域以及一个位于C末端的单一HV-BBI编码结构域。研究发现,在假定的P1位置具有野生型K(赖氨酸-8)残基的HV-BBI合成复制品是一种有效的胰蛋白酶抑制剂,其抑制常数(K(i))略小于19 nM。该位点被R(精氨酸)取代会导致效力显著降低(K(i)为57 nM),而用F(苯丙氨酸)取代K则会导致胰蛋白酶抑制活性完全丧失。因此,HV-BBI是一种有效的胰蛋白酶抑制剂,占据P1位置的赖氨酰(K)残基似乎是针对这种蛋白酶发挥作用效力的最佳选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验